Polyphenols are an extensive group of secondary metabolites. Several studies have suggested that these natural plant compounds may help in the prevention and treatment of cancer. These metabolites present in fruits, vegetables, cereals, and other plant sources have demonstrated their potential to reduce cancer risk due to their antioxidant, anti-inflammatory, and antiproliferative properties. They can be obtained from plant sources using various conventional and environmentally friendly methods, often leading to higher yields. They can exert their anticancer potential through multiple molecular mechanisms, such as induction of apoptosis, inhibition of angiogenesis, and modulation of cell cycle progression. In addition, polyphenols have demonstrated efficacy in vitro, in vivo, and in silico models, with promising results in several types of cancer. Preclinical findings show potential, but further studies are needed to understand their clinical application fully, especially in refining doses and methods of polyphenol delivery for cancer treatment.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Introduction

  • Cristina Alicia Elizalde-Romero,
  • Melissa García-Carrasco,
  • Luis Angel Cabanillas-Bojórquez,
  • Luis Aurelio Montoya-Inzunza,
  • Erick Paul Gutiérrez Grijalva,
  • Marilyn Shomara Criollo-Mendoza

摘要

Polyphenols are an extensive group of secondary metabolites. Several studies have suggested that these natural plant compounds may help in the prevention and treatment of cancer. These metabolites present in fruits, vegetables, cereals, and other plant sources have demonstrated their potential to reduce cancer risk due to their antioxidant, anti-inflammatory, and antiproliferative properties. They can be obtained from plant sources using various conventional and environmentally friendly methods, often leading to higher yields. They can exert their anticancer potential through multiple molecular mechanisms, such as induction of apoptosis, inhibition of angiogenesis, and modulation of cell cycle progression. In addition, polyphenols have demonstrated efficacy in vitro, in vivo, and in silico models, with promising results in several types of cancer. Preclinical findings show potential, but further studies are needed to understand their clinical application fully, especially in refining doses and methods of polyphenol delivery for cancer treatment.